by Sara M. Nolte | Jul 14, 2022
Almost two years ago, I wrote a post about how scientists were looking for new immunotherapies to improve immunologically “cold” tumours’ responses to existing therapies. And while the findings of that article were very promising, tumour evasion of the immune system...
by Lyla El-Fayomi | Jul 7, 2022
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I sample the latest and greatest findings in recent press and package them into a single post. In this double issue, I cover a gene therapy for...
by Cal Strode | Jun 30, 2022
When I heard that the International Society for Stem Cell Research (ISSCR) was hosting a public symposium to ask if regenerative medicine can turn back the clock on aging, my interest was piqued. The enthusiasm for putting the brakes on aging has been documented as...
by Stacey Johnson | Jun 24, 2022
Long before Bruce Willis’ family announced his aphasia diagnosis to the world, I witnessed the effects of it firsthand through someone in my extended family. Aphasia is characterized by difficulty communicating verbally and in writing, and the most common cause of...
by Lyla El-Fayomi | May 10, 2022
“Regenerative medicine news under the microscope” is a monthly feature highlighting big stories in stem cell research. I will sample the latest and greatest findings in recent press and package them into a single post. April was full of great research and big...
by Sara M. Nolte | Apr 28, 2022
If I were to ask you to think of a genetic disease that should be a priority for gene therapy research, you might say breast cancer, Huntington’s, or cystic fibrosis. And these are all great candidates. But I’d say you’re missing a big one. Sickle cell disease (SCD)...
Comments